BioWorld

July 29, 2002

View Archived Issues

Ricerca's Infectious Disease Area Established Via Deal With Genset

Read More

Transgenic Mouse Experiments Show Clusterin Protein Has Hand In Alzheimer's Plaque Formation

Read More

Scios Planning Private Offering Of $125M In Convertible Notes

Read More

Other News To Note

Read More

Quarterly Earnings Reports

Read More

OGS Gains European Approval, Partner For Gaucher's Product

LONDON - Oxford GlycoSciences plc said Friday it received approval in Europe for Vevesca, an oral treatment for Gaucher's disease that was turned down by the FDA on June 24. (BioWorld Today) Read More